Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
1.68
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-0.97 Insider Own3.13% Shs Outstand11.43M Perf Week-14.29%
Market Cap0.96M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.55M Perf Month-10.16%
Income-5.93M PEG- EPS next Q- Inst Own1.62% Short Float1.01% Perf Quarter-16.00%
Sales1.97M P/S0.49 EPS this Y- Inst Trans- Short Ratio0.01 Perf Half Y-46.11%
Book/sh1.28 P/B1.31 EPS next Y- ROA-18.81% Short Interest0.01M Perf Year-76.00%
Cash/sh30.47 P/C0.06 EPS next 5Y- ROE-38.15% 52W Range1.56 - 9.38 Perf YTD-57.68%
Dividend Est.- P/FCF- EPS past 5Y- ROI-39.42% 52W High-82.08% Beta1.01
Dividend TTM- Quick Ratio1.31 Sales past 5Y-20.74% Gross Margin21.62% 52W Low7.69% ATR (14)0.19
Dividend Ex-Date- Current Ratio1.35 EPS Y/Y TTM96.76% Oper. Margin-284.40% RSI (14)41.91 Volatility8.10% 9.39%
Employees78 Debt/Eq0.26 Sales Y/Y TTM-24.23% Profit Margin-301.00% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.03 EPS Q/Q- Payout- Rel Volume0.06 Prev Close1.68
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume1.09M Price1.68
SMA20-8.97% SMA50-11.14% SMA200-44.30% Trades Volume60,713 Change0.00%
Oct-26-23 04:05PM
Oct-04-23 08:30AM
Aug-02-23 06:03AM
May-10-23 08:00AM
Mar-29-23 09:43AM
08:00AM Loading…
Nov-07-22 08:00AM
May-18-22 12:30PM
Mar-14-22 10:33PM
Jan-20-22 12:30PM
10:45AM
Jan-18-22 07:46AM
06:47AM
Jan-14-22 05:43PM
02:00PM
Dec-16-21 08:00AM
08:00AM Loading…
Oct-18-21 08:00AM
Feb-19-21 08:00AM
Nov-26-20 08:16PM
Sep-09-20 09:00AM
May-29-20 03:08PM
Mar-16-20 09:00AM
Jan-28-20 09:35AM
Jan-24-20 02:23PM
Jan-16-20 08:00AM
Jan-03-20 10:30AM
Dec-04-19 07:10AM
Nov-14-19 11:30AM
Sep-11-19 07:00AM
Aug-19-19 08:00AM
Aug-12-19 08:00AM
08:00AM Loading…
Jul-03-19 08:00AM
May-22-19 11:20AM
Apr-17-19 09:00AM
Apr-02-19 06:30AM
Mar-28-19 06:30AM
Jan-30-19 02:25PM
Jan-04-19 07:30AM
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). Its product categories include directly-oral, after-soaking-oral, fine, and regular TCMP. The firm distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.